Trailing-twelve-month (TTM) revenue is $4.46 Billion with a year-over-year growth of +57.87%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $769,210,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $1,083,337,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-29 | $1,282,494,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-28 | $1,328,990,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $4,464,031,000 |
Current P/S: $59,986,478,290 market capitalization ÷ $4,464,031,000 TTM revenue = 13.44x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-28): $1.33B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $2.7B | $3.2B | $2.6B | $2.1B | $2.3B | $2.7B |
| Service | $431M | $506M | $563M | $580M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $466M | $632M | $492M | $315M | $375M | $451M |
| EMEA | $206M | $260M | $268M | $274M |
$4.46B
$4.46 Billion
+57.87%
vs. $2.83B a year ago (TTM)
+6.58%
5 Year compound annual growth rate
1 Year
+57.87%
3 Year
+12.86%
5 Year
+6.58%
10 Year
+9.72%
15 Year
+6.81%
20 Year
+7.97%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.19B | +$370.14M | +13.13% |
| 2024 | $2.82B | +$143.58M | +5.36% |
| 2023 | $2.68B | ($478.75M) | (15.17%) |
| 2022 | $3.16B | ($547.84M) | (14.79%) |
| 2021 | $3.70B | +$581.41M | +18.63% |
| 2020 |
TTM Growth
+57.87%
3-Year CAGR
+12.86%
5-Year CAGR
+6.58%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $530M |
| $215M |
| JAPAN | $144M | $166M | $163M | $282M | $160M | $66M |
|---|
| KOREA, REPUBLIC OF | $392M | $502M | $545M | $395M | $696M | $446M |
|---|
| MALAYSIA | $56M | $137M | $142M | $89M | $62M | $107M |
|---|
| PHILIPPINES | $69M | $167M | $124M | $189M | $54M | $93M |
|---|
| Rest of World | $75M | $68M | $88M | $105M | $106M | $133M |
|---|
| SINGAPORE | $76M | $122M | $100M | $117M | $90M | $95M |
|---|
| TAIWAN, PROVINCE OF CHINA | $1.2B | $1.1B | $626M | $385M | $602M | $1.2B |
|---|
| THAILAND | $139M | $139M | $137M | $92M | $49M | $68M |
|---|
| UNITED STATES | $322M | $393M | $470M | $434M | $374M | $361M |
|---|
| $3.12B |
| +$826.50M |
| +36.01% |
| 2019 | $2.29B | +$194.16M | +9.24% |
| 2018 | $2.10B | ($35.80M) | (1.68%) |
| 2017 | $2.14B | +$383.36M | +21.87% |
| 2016 | $1.75B | +$113.67M | +6.93% |
